Pulmonx Corp (LUNG): Cost of Revenue
$23.36M
Year ended 2025-12-31
$20.06M
Trailing 12 months to 2026-06-30
+19.2%
3-year compound annual growth
+15.2%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $23.36M | +7.2% | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | $21.79M | +21.6% | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | $17.92M | +29.9% | 2025-02-25, From 2023-01-01 |
| 2022-12-31 | $13.80M | +7.9% | 2024-02-27, From 2022-01-01 |
| 2021-12-31 | $12.79M | +10.9% | 2023-03-01, From 2021-01-01 |
| 2020-12-31 | $11.53M | +13.3% | 2022-03-01, From 2020-01-01 |
| 2019-12-31 | $10.18M | +31.9% | 2021-03-15, From 2019-01-01 |
| 2018-12-31 | $7.72M | n/a | 2021-03-15, From 2018-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Pulmonx Corp (LUNG) | 2025-12-31 | $23.36M | +7.2% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $46.26M | +29.9% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $11.80M | +90.6% |
| Iradimed Corp (IRMD) | 2025-12-31 | $19.49M | +15.4% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $22.77M | +9.3% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $44.71M | +52.9% |
| PRO DEX Inc (PDEX) | 2026-06-30 | $53.21M | +13.0% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $10.70M | -7.6% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $49.01M | +11.6% |
Compare LUNG, KMTS, DCTH, IRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗